International Patent: ENGINEERED CAS12 PROTEIN AND USE THEREOF

GENEVA, July 31 -- ACCUREDIT THERAPEUTICS (SUZHOU) CO., LTD. filed a patent application (CN2026/075196) for “ENGINEERED CAS12 PROTEIN AND USE THEREOF”. With publication no. WO/2026/158700, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 9/22

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....